We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Amarin Says Supplement Cos. Can't Tout Its Omega-3 Trial

Law360 (October 30, 2018, 6:52 PM EDT) -- Amarin Pharma Inc. has accused two supplement makers in California federal court of undercutting the reputation of its U.S. Food and Drug Administration-approved medication Vascepa by relying on its clinical trial...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

California Central

Nature of Suit

890(Other Statutory Actions)

Date Filed

October 29, 2018


Case Title

Subscribers Only

Case Number

Subscribers Only

Court

California Southern

Nature of Suit

890(Other Statutory Actions)

Judge

Subscribers Only

Date Filed

October 29, 2018

Law Firms

Government Agencies

Judge Analytics

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.